Charming Medical (MCTA) Faces Class Action Over Stock Surge and Fraud Allegations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5h ago
0mins
Source: PRnewswire
- Class Action Filed: A federal securities class action has been initiated against Charming Medical (NASDAQ:MCTA) for stock transactions between October 21 and November 12, 2025, with a lead plaintiff deadline set for February 17, 2026, aimed at recovering losses from misleading promotions.
- Stock Price Surge: Following its IPO, Charming Medical's stock price skyrocketed from $4.00 to $29.36 per share without any fundamental news, indicating the artificial nature of this price increase.
- Fraud Allegations: The lawsuit alleges that impersonators posing as financial advisors promoted Charming Medical through social media, making sensational and unsupported claims that misled retail investors into buying the stock, resulting in significant losses.
- Trading Suspension Impact: In November 2025, trading of Charming Medical securities was suspended, exposing the fraudulent nature of the stock price surge and prompting affected investors to seek legal recourse for their financial damages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
